Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STAG3 cohesin complex component like 5, pseudogene (STAG3L5P) is classified as a **pseudogene**, meaning it is a genomic DNA sequence similar to a known gene but considered non-functional due to loss of protein-coding ability[1][5][6]. Pseudogenes like STAG3L5P do **not** encode functional proteins and, in most databases, are not listed as therapeutic targets, enzymes, transporters, receptors, or direct disease-related genes[1][5][6]. Some pseudogenes can have regulatory functions at the RNA level, such as acting as decoys for microRNAs or regulating parental gene expression, but no such function has been described for STAG3L5P[3][4][7]. There are **no reported drugs, biomarkers, or therapeutic roles** for this sequence, and it is generally not considered relevant to therapeutic targeting.
None known (drug targeting or mechanism does not apply to STAG3L5P as it is a non-coding pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STAG3 cohesin complex component like 5, pseudogene (STAG3L5P).